Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 883.4M | 614.4M | 486.8M | 316.4M | 216.1M | 208.5M | 206.5M | 201.6M | 176.8M | 128.6M | 76.3M | 56.0M | 30.1M | 20.4M | 435,160 | 2.5M | 1.3M |
| Gross Profit | — | — | — | — | — | 121.3M | 143.4M | 128.6M | 97.8M | 79.8M | 63.6M | 44.5M | 20.1M | 11.2M | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | 111.1M | 584,000 | 47.0M | -35.3M | -39.8M | -16.0M | 16.4M | 35.4M | 28.3M | 20.1M | 32.7M | 20.0M | 898,000 | -42,000 | — | — | — |
| EBITDA | 202.5M | 68.3M | 106.8M | 21.7M | 7.5M | 28.6M | 61.0M | 69.1M | 56.3M | 42.4M | 39.6M | 23.9M | 2.0M | 525,000 | — | — | — |
| Net Income | 78.3M | -18.5M | 18.8M | -47.9M | -42.6M | -22.5M | 6.1M | 15.5M | -1.1M | 3.9M | 15.4M | 28.7M | 301,000 | -1.5M | — | — | — |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 21M | 19M | 18M | 16M | 13M | 12M | 12M | 12M | 12M | 12M | 12M | 11M | 0M | 22M | 16M | 11M | 34M |
Ani Pharmaceuticals Inc. Income Statement — FAQ
Ani Pharmaceuticals Inc. (ANIP) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIP's income statement history?
The chart and table above show Ani Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.